You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

~ Buy the LEVULAN (aminolevulinic acid hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR LEVULAN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LEVULAN

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00524485 ↗	Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis	Terminated	National Cancer Institute (NCI)	N/A	2005-05-01	RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis.
NCT00524485 ↗	Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis	Terminated	Roswell Park Cancer Institute	N/A	2005-05-01	RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis.
NCT00706433 ↗	Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne	Completed	DUSA Pharmaceuticals, Inc.	Phase 2	2007-03-01	The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LEVULAN

Condition Name

Chart
Table

Condition Name for LEVULAN
Intervention	Trials
Actinic Keratosis	9
Keratosis, Actinic	3
Basal Cell Nevus Syndrome	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LEVULAN
Intervention	Trials
Keratosis, Actinic	16
Keratosis	16
Carcinoma	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LEVULAN

Trials by Country

Map
Table

Trials by Country for LEVULAN
Location	Trials
United States	86
Finland	1
Saudi Arabia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LEVULAN
Location	Trials
California	12
Texas	9
Indiana	8
Florida	7
Minnesota	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LEVULAN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LEVULAN
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	3
Phase 2	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LEVULAN
Clinical Trial Phase	Trials
Completed	20
Terminated	3
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEVULAN

Sponsor Name

Chart
Table

Sponsor Name for LEVULAN
Sponsor	Trials
DUSA Pharmaceuticals, Inc.	15
National Cancer Institute (NCI)	3
Harry T Whelan, MD	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LEVULAN
Sponsor	Trials
Other	21
Industry	16
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.